← Back to headlines
Eli Lilly Expands Pipeline with Positive Trial Data and New Licensing Deal
Eli Lilly (LLY) has announced the expansion of its pharmaceutical pipeline, driven by positive trial data and a new licensing agreement.
23 Feb, 19:51 — 23 Feb, 19:51
ℹOnly 1 source covers this story
